FDA Warns Against Hyperbaric Oxygen Therapy for Autism

Source: 
U.S. Food and Drug Administration
Date Published: 
August 22, 2013
Abstract: 

The FDA has issued a warning against using Hyperbaric Oxygen Therapy (HBOT) in the treatment of autism. HBOT involves breathing oxygen in a pressurized chamber. This treatment has not been cleared by the FDA for the treatment of autism, though there are some places on the internet that falsely claim it has. The FDA urges people to work with their health care professional to determine their best choice for treatment.